A detailed history of Northern Financial Advisors Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Northern Financial Advisors Inc holds 3,575 shares of ABBV stock, worth $595,309. This represents 0.51% of its overall portfolio holdings.

Number of Shares
3,575
Previous 3,595 0.56%
Holding current value
$595,309
Previous $557 Million 16.84%
% of portfolio
0.51%
Previous 0.47%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$159.82 - $182.1 $3,196 - $3,642
-20 Reduced 0.56%
3,575 $651 Million
Q4 2023

Feb 06, 2024

SELL
$137.6 - $154.97 $129,894 - $146,291
-944 Reduced 20.8%
3,595 $557 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $88,436 - $102,378
662 Added 17.08%
4,539 $677 Million
Q2 2023

Jul 21, 2023

SELL
$132.51 - $164.9 $104,285 - $129,776
-787 Reduced 16.87%
3,877 $522 Million
Q1 2023

Apr 26, 2023

BUY
$144.61 - $166.54 $674,461 - $776,742
4,664 New
4,664 $743 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $294B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Northern Financial Advisors Inc Portfolio

Follow Northern Financial Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Financial Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northern Financial Advisors Inc with notifications on news.